"Drugs that originate from public health organizations in Brazil or India are often different in key ways from ones developed by a pharmaceutical company in an industrialized country, Dr. Kratz said: The scientists creating them think about access from the start, knowing that whatever they design will have to be delivered by a low-resource health system."

https://www.nytimes.com/2023/12/19/health/leishmaniasis-fly-treatment-colombia.html?unlocked_article_code=1.HE0.XrPX.y5IlLyEZAMXt&smid=nytcore-ios-share&referringSource=articleShare